Nicox

Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent

Press Release

Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent

April 24, 2024 – release at 07:30 CET Sophia Antipolis, France

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, informs its shareholders that the Ordinary and Extraordinary General Meeting, having been unable to deliberate on April 10, 2024 as the quorum required by law has not been reached, will be held, on second convening, on Monday May 6, 2024 at 2:30 p.m., at the offices of BuroClub - Drakkar 2 Bâtiment D - 2405 route des Dolines - 06560 Valbonne Sophia Antipolis.



The agenda and the draft resolutions for the Ordinary and Extraordinary Shareholders' Meetings remain unchanged and are included in the notice of meeting published in Bulletin des Annonces Légales Obligatoires no.36 of March 22, 2024 (no. 2400592).



Appointment of an ad hoc agent to represent shareholders



By order of the President of the Antibes Commercial Court on April 18, 2024, given the impossibility of reaching the required quorum, SELARL XAVIER HUERTAS & ASSOCIES, in the person of Maître Xavier Huertas, domiciled at 1, Rue Lamartine - 06000 Nice, was appointed as ad hoc agent to represent the shareholders at the Ordinary and Extraordinary General Meeting convened for May 6, 2024 on second convening.



The ad hoc agent will thus represent all the shares with voting rights held by shareholders who have not attended or are not represented at this General Meeting. The participation of the ad hoc agent would thus bring the quorum to 100% of shares with voting rights.



In order to ensure the neutrality of the ad hoc agent, the voting rights attached to the shares of the represent shareholders will be exercised as follows:

• for ordinary resolutions, whether submitted, approved or not approved by the Board of Directors: half the votes in favor and half against;
• for extraordinary resolutions submitted or approved by the Board of Directors: two-thirds in favor and one-third against;
• for extraordinary resolutions not approved by the Board of Directors: one-third in favor and two-thirds against;